Gem Collectors AMA with Triall

Chad Roulette
Gem Collectors AMA’s
22 min readMay 19, 2021

--

Chad Roulette, [19.05.21 20:59]
Welcome Triall!

Bill Grimes, [19.05.21 20:59]
Good evening and welcome to our community @rxvdwaal !🙏

Raymond van der Waal, [19.05.21 21:00]
Hi everyone, great to be here, look forward to answering all of your questions

Bill Grimes, [19.05.21 21:01]
Awesome! We’re very curious about Triall!

Raymond van der Waal, [19.05.21 21:02]
That’s great, love to tell you all about our project in this coming hour

Chad Roulette, [19.05.21 21:02]
Shall we get started right away? We usually like to start off with an introductory question. Our community members that haven’t heard of Triall before are curious, what is this project exactly? Can you explain us a bit about Triall?

Raymond van der Waal, [19.05.21 21:03]
Sure

Raymond van der Waal, [19.05.21 21:03]
So very briefly an intro of myself: I’m Raymond van der Waal, co-founder and Head of Marketing at Triall.io. My background is in biomedical sciences and Life Sciences business management and I have previously built experience as a researcher, entrepreneur, and consultant

Raymond van der Waal, [19.05.21 21:04]
With Triall we’re bringing web 3.0 to medical research

Raymond van der Waal, [19.05.21 21:04]
We develop blockchain-integrated software solutions that promote the reliability and efficiency of clinical trials

Raymond van der Waal, [19.05.21 21:05]
Clinical trials are research studies that evaluate the safety and efficacy of new medicines before these enter the market. This is a lengthy process that typically takes 10 years and a huge market (the pharma industry spends almost $200B on clinical trials each year)

Raymond van der Waal, [19.05.21 21:05]
By using blockchain and other related technologies, our solutions optimize data integrity, auditability, and operational efficiency in clinical trials

Raymond van der Waal, [19.05.21 21:06]
Our mission is to accelerate the introduction of safe and affordable vaccines and therapeutics into society by streamlining clinical trial operations 🙂

Chad Roulette, [19.05.21 21:06]
That is a gigantic market! Thanks for the clear introduction!

Bill Grimes, [19.05.21 21:07]
Great to get an insight into this industry and to hear some more about you Raymond!

Raymond van der Waal, [19.05.21 21:07]
🙏🏽

Bill Grimes, [19.05.21 21:08]
We’re always interested in the backstory behind a project of such revolutionary size. When and why was Triall founded?

Raymond van der Waal, [19.05.21 21:08]
So Triall started about 4 years ago to answer a number of recurring issues in our industry that make clinical trials overly complex, lengthy, and resource inefficient

Raymond van der Waal, [19.05.21 21:10]
Part of our team members have been operating in the clinical trial industry for over 20 years and witnessed these issues that mainly related to data fragmentation, where data is often scattered across different locations, systems, and hospitals -> which leads to a lack of oversight, delays, and unnecessary costs for many clinical trial stakeholders

Raymond van der Waal, [19.05.21 21:10]
Another part of our team was conducting research on the implications of blockchain on the Life Sciences / healthcare industry at large

Raymond van der Waal, [19.05.21 21:11]
And in 2017, when these two groups came together, we started connecting the dots and realized how the unique properties of blockchain could be used to address several of the issues we had identified

Bill Grimes, [19.05.21 21:12]
Quite the interesting backstory, it’s been quite a while then for Triall. 4 years of hard work!

Raymond van der Waal, [19.05.21 21:13]
Yes, we’ve put a lot of time, effort, and thinking into this project

Bill Grimes, [19.05.21 21:13]
It’s something every investor appreciates a lot. We’ve seen the opposite of this a bit too often as crypto traders ;)

Raymond van der Waal, [19.05.21 21:14]
Fast-forward to today, we have built a fully operational business with a commercial product and a surrounding network of partners and advisors that have been invaluable to the shaping of our vision and the materialization of our roadmap

Raymond van der Waal, [19.05.21 21:15]
[In reply to Bill Grimes]
Yes a lot of project are just jumping on the hype

Raymond van der Waal, [19.05.21 21:15]
We want to build a sustainable platform that can survive for 30–40+ years

Bill Grimes, [19.05.21 21:17]
This is great to hear Raymond. Thanks for transparency, we appreciate it

Bill Grimes, [19.05.21 21:17]
As Chad suggested, let us shine some light on the team behind Triall. What can you tell us about them? Previous work, crypto-related experience, field of work, etc.

Raymond van der Waal, [19.05.21 21:17]
Sure

Raymond van der Waal, [19.05.21 21:18]
We bring together a group of clinical operations experts, enterprise IT specialists, and blockchain developers who all share a vision of making clinical trails more reliable and efficient using blockchain. I think it also really helps that we have all worked together over the past 10–12 years both in business and academia

Raymond van der Waal, [19.05.21 21:19]
Combined, our team has managed 100+ clinical trials and co-founded 20+ ventures in Life Sciences and B2B software. This experience has left us with deep roots in the clinical trial industry and strong ties to blockchain and IT standards groups (W3C, DIF, IEEE)

Raymond van der Waal, [19.05.21 21:19]
These connections allow us to rapidly pilot test new software features with professionals who are working in clinical trials on a daily basis. It also provides us with the insights and network to continue operating at the forefront of industry developments

Chad Roulette, [19.05.21 21:21]
It sounds like a great team with a lot of experience!

Chad Roulette, [19.05.21 21:21]
[In reply to Raymond van der Waal]
I had another question about this:

Raymond van der Waal, [19.05.21 21:22]
No problem, please do ask ;)

Chad Roulette, [19.05.21 21:23]
[In reply to Raymond van der Waal]
This is always very nice to hear, I am also very curious what your vision is with Triall in 2–4 years?

Raymond van der Waal, [19.05.21 21:23]
Excellent question

Raymond van der Waal, [19.05.21 21:24]
So we developed and commercialized our first application Verial eTMF over the past years. This is a blockhain-integrated document management solution that enables clinical trial professionals to generate verifiable proofs of the integrity and existence of their trial-related documents

Raymond van der Waal, [19.05.21 21:25]
Next to Verial eTMF we’re working on several other follow-on solutions that we will release over the coming period. These solutions will all be integrated with each other and focus on different functions. Where Verial eTMF focuses on document management. Triall CTMS, for instance, will focus on planning & oversight.

Raymond van der Waal, [19.05.21 21:26]
In parallel to building our own in-house solutions we will double down on interoperability by offering APIs that enable 3rd party clincial trial software providers to integrate with our infrastructure, providing them with an easy entry into our blockchain functionalities and allowing them to communicate with the other solutions part of our platform

Raymond van der Waal, [19.05.21 21:26]
This will gradually shape what we call a ‘digital ecosystem for clinical trials’: the Triall ecosystem

Raymond van der Waal, [19.05.21 21:26]
Essentially a one-stop-shop for clinical trial professionals, where they can find all of their software needs in one place :)

Chad Roulette, [19.05.21 21:28]
This is a great vision, I am already looking forward to the coming period!

Bill Grimes, [19.05.21 21:28]
Thanks for the explanation! Very clear. It seems like Triall will be a center point in the industry

Raymond van der Waal, [19.05.21 21:28]
Thanks guys

Bill Grimes, [19.05.21 21:29]
In such a model that Triall is building, which parties are involved? Could you quickly go over the process of current clinical trials and how your company will revolutionise and digitalise this system? Perhaps in layman terms for us who are not so familiar with this industry (e.g. me)😜

Raymond van der Waal, [19.05.21 21:29]
Sure

Raymond van der Waal, [19.05.21 21:30]
Clinical trials are initiated by a so-called ‘sponsor’ which is usually a pharma, biotech or medical device company that wants to test its new product. The actual patient visits take place in a hospital (‘site’), where the patient recieves his/her medication and where the majority of test results are collected. Quite often a contract research organization (‘CRO’) is involved to manage all of this

Raymond van der Waal, [19.05.21 21:31]
So our software is designed for the Sponsor, CROs, and Sites and eventuelly we will also extend to the patient-level

Raymond van der Waal, [19.05.21 21:32]
We see that many clinical trial stakeholders are currently hampered by suboptimal software infrastructures. This stems from legacy software, limited options for integrations, general-purpose solutions that aren’t designed for clinical research, etc.

Raymond van der Waal, [19.05.21 21:33]
Our software solutions are designed for and by clinical trial professionals. In simple terms: they support these organizations in conducting their work more efficiently while also using blockchain to answer several industry-wide needs:

Raymond van der Waal, [19.05.21 21:33]
(1) promoting traceability and auditability of clinical trial operations, which have become increasingly complex and data-heavy; and
(2) enabling the safe and compliant transfer of clinical trial data between organizations and systems, thereby promoting interoperability and tackling data fragmentation

Bill Grimes, [19.05.21 21:35]
Wow! This definitely gives a peek behind the scenes of these clinical trials. The blockchain solution seems to fit in very well for this particular industry

Raymond van der Waal, [19.05.21 21:36]
Yes, we think blockchain is a great fit, due to the growing number of data integrity issues, the extremely long timelines, the high amount of stakeholders involved, and a few other reasons 😜

Bill Grimes, [19.05.21 21:36]
Although this seems like a real solution for many blockchain enthusiasts, I can imagine that the position Triall is filling in the market will have polarised views. How is the arrival of Triall received? In other words, are you making friends or enemies by entering this market? Which of the two and why?

Raymond van der Waal, [19.05.21 21:37]
Well having worked on this for 4 years now I’ve definitely seen a shift

Raymond van der Waal, [19.05.21 21:37]
4 years ago, most clinical trial professionals associated blockchain with Bitcoin only

Raymond van der Waal, [19.05.21 21:37]
Nowadays, this perception has shifted

Raymond van der Waal, [19.05.21 21:38]
You see a lot of industry-wide initiatives that are trying to research the implications of blockchain in a pilot/non-commercial setting

Raymond van der Waal, [19.05.21 21:38]
There’s a growing body of scientific research that underlines the value of blockchain for clinical trials and the life sciences at large

Raymond van der Waal, [19.05.21 21:38]
So the industry is looking a lot more favourable to the technology comparted to 4 years ago

Raymond van der Waal, [19.05.21 21:39]
On the other side: the blockchain space has also made a lot of progress in terms of technological developments and maturity

Raymond van der Waal, [19.05.21 21:39]
We’re still in the early days, but you see a lot of very interesting innovations being developed in so many different industries

Raymond van der Waal, [19.05.21 21:40]
Proper education and assurance about the compliance of our software solutions with specific industry requirtements is needed, and that’s a need that we’re covering with our team and advisors :)

Bill Grimes, [19.05.21 21:40]
[In reply to Raymond van der Waal]
This was (and sometimes still is) a common view among a lot of industries that haven’t yet been introduced to blockchain. It’s great to see that Triall is working in an industry that’s getting used to this new technology. This is definitely a barrier less!

Bill Grimes, [19.05.21 21:41]
Exactly! The more education that is given, the more understood it will become

Raymond van der Waal, [19.05.21 21:42]
For many clinical trial professionals it will just be a ‘back-end technology’. They’re just interested in the end-result, that blockchain plays an important part in achieving that end-result is less important for them

Chad Roulette, [19.05.21 21:43]
You explain everything very clearly @rxvdwaal Thanks!

Raymond van der Waal, [19.05.21 21:44]
No problem, that’s also one of my roles here at Triall… making our value propisition explainable and understandable to the larger audience :)

Chad Roulette, [19.05.21 21:44]
As crypto investors we are always very interested in the launch of new projects that have strong ‘fundamentals’. Can you tell us a bit more about the upcoming token listing of TRIALL? When will this commence? What will the tokenomics be?

Raymond van der Waal, [19.05.21 21:44]
Sure

Raymond van der Waal, [19.05.21 21:45]
So we’re currently in the midst of our pre-sale campaign. I welcome everyone to register their interest on our website triall.io

Raymond van der Waal, [19.05.21 21:45]
It looks like we probably will have our TGE in about 6 weeks. Straight after closing the pre-sale

Raymond van der Waal, [19.05.21 21:45]
Our TGE will coincide with listing on Uniswap

Raymond van der Waal, [19.05.21 21:46]
We plan to issue a total of 175M $TRL tokens. Due to our vesting schedules, the circulating supply at the time of our TGE will only be 3.666.250 TRL (2,10% of the total supply), which translates into a Market Cap of $ 916.564,-

Raymond van der Waal, [19.05.21 21:46]
So maybe I should briefly explain the utility of TRL and our internal counterpart T-CRED

Bill Grimes, [19.05.21 21:47]
Please do! We’re curious about the role of the TRL currency

Chad Roulette, [19.05.21 21:48]
Yes please!

Raymond van der Waal, [19.05.21 21:48]
The core utilities of our two-token system are:
- Means of payment for all Triall solutions: by converting TRL to T-CRED. Where software subscriptions are paid using T-CRED. And software providers can convert their collected T-CRED back to TRL.
- P2P compensation of stakeholders in the ecosystem: think sponsors paying sites for instance
- Engage and incentivize community members for providing value to the ecosystem: development, bug hunting, best practices, etc.
- Governance: include stakeholders in setting the course of the ecosystem
- Memberships & community rewards: loyalty programs with rewards for end-users and community members

Bill Grimes, [19.05.21 21:51]
Quite a list of purposes for the TRL token. Especially the community engagement and rewards will be interesting and I like these incentives

Bill Grimes, [19.05.21 21:52]
Regarding the TGE, will it commence through IDO platforms and if so, which?

Raymond van der Waal, [19.05.21 21:52]
We’re currently in talks with multiple launch pads

Raymond van der Waal, [19.05.21 21:53]
I think I’m at liberty to say that one will be Mantra DAO

Raymond van der Waal, [19.05.21 21:53]
The plan is to do 2–3 launch pads in June

Raymond van der Waal, [19.05.21 21:53]
To grow our initiative and tap into new networks

Bill Grimes, [19.05.21 21:53]
[In reply to Raymond van der Waal]
Wow! Awesome platform

Bill Grimes, [19.05.21 21:54]
Thanks again for the transparency

Raymond van der Waal, [19.05.21 21:54]
Looking for launch pads, investors, partners, advisors that believe in real-world applications and with a long-term view to blockchain and crypto :)

Bill Grimes, [19.05.21 21:54]
[In reply to Raymond van der Waal]
You’ve got our support for sure!

Raymond van der Waal, [19.05.21 21:55]
[In reply to Bill Grimes]
🙏🏽

Chad Roulette, [19.05.21 21:55]
[In reply to Bill Grimes]
Absolutely!

Chad Roulette, [19.05.21 21:56]
Would you like to share anything with the community before we move to the community questions?

Raymond van der Waal, [19.05.21 21:57]
No I think that provided quite a comprehensive view of our project, plans, and vision

Chad Roulette, [19.05.21 21:58]
Perfect! It was indeed very clear, I am curious what questions the community has!

Chad Roulette, [19.05.21 21:58]
Are you ready guys?

Bill Grimes, [19.05.21 21:59]
The chat will be opened in a minute and the community will have the opportunity to ask some questions. Once the chat is closed again, you can filter out some questions and answer. Eventually only one of the questions can win the prize of ‘the-best-question’ and this person will be rewarded 😄

Raymond van der Waal, [19.05.21 21:59]
👍🏼

Chad Roulette, [19.05.21 21:59]
Goodluck!

Bill Grimes, [19.05.21 22:00]
/on@amaguardbot

AMA Guard, [19.05.21 22:00]
Group Gem Collectors 💎 session is now Active

Veloraa $ C R Y P T O, [19.05.21 22:00]
Hii Sir. @rxvdwaal

Q1.. Can I ask you about, Why do you need a blockchain for your project and literally how it can help the health sector..??
(Please briefly describe the role of the “Triall” Project.)

Q2. And can you tell more about a “Triall” community fund.?
What % of the tokens are reserved for this fund and what is their purpose..??

Rajashree 1⃣ 1⃣ 1⃣, [19.05.21 22:00]
What plans do you have to aware and educate about TRIALL for the people globally ? How do you plan to increase adoption those who are not in crypto?

@rxvdwaal

Lontong Balap | soon mustang, [19.05.21 22:00]
Many scam projects in the market. I would like to invest in your project but I habe doubt. Can you assure us that you are not like others and there is no chance of scam?

Aurellia, [19.05.21 22:00]
Could you tell us a little about your greatest achievements this year, what are you working on right now? What are the main thoughts you want to convey through today’s AMA?

Abdullah, [19.05.21 22:00]
You stated on your website that Triall is laying the groundwork for tomorrow’s digital playing field in medical research and clinical trials.

Your project seems to have its target audience as medical professionals. Can you tell us how you intend to capture other people not in medical line?

kenny kimora, [19.05.21 22:00]
Hayy sir @rxvdwaal
Recently, Triall tackled some of the persistent issues currently felt by the clinical trial industry. So how does Triall use blockchain technology to realize the future of digital healthcare and how can blockchain technology empower the traditional clinical trial industry? And Has your project been completely decentralized, and will there be any risk of centralization in the future?

🐰🐰karina🐰🐰, [19.05.21 22:00]
What does it mean to be an interoperable blockchain agnostic platform? How will this unique feature affect the #TRIALL vision / mission? Do you have the deadly features to beat the competitors that make you confident?

Ayam Racing, [19.05.21 22:00]
🤔Describe your main features that differentiate your project from other projects and what competitive advantages do you have for the current project?

🤭Could you please provide some progress on your Roadmap and what results Triall has achieved so far ? And any sneak peek into 2021 plans for Triall?

Lontong Balap | soon mustang, [19.05.21 22:00]
Describe your main features that differentiate your project from other projects and what competitive advantages do you have for the current project?

Leo, [19.05.21 22:00]
Hello @rxvdwaal

1.You have a very exciting background and have a pretty big ambitious project for long term years of 30_40 but from a bio medical science background what inspired you to work in the blockchain industry? How did you get involved in crypto?

2.How will you sustain your project for such a long period what is your business module and revenue plans?

🌼 Seoyun 서윤 🌼, [19.05.21 22:00]
In addition to being a project that offers solutions for the medical sector, Triall will need partnerships from both the medical sector and the crypto sector, as it integrates these solutions into the Blockchain system.

Therefore, can you give information about your planned and realized partnerships from both sectors in order to further strengthen your ecosystem?
What is your strategy to develop and strengthen your ecosystem?

Geby, [19.05.21 22:00]
Whether the TRIALL platform will only focus on robo-trading, or in the future there are other features such as staking, swap, NFT market and others. Is there something that will stand out on your platform in the future besides robo trading

Jessica, [19.05.21 22:00]
Does the name #Triall have a meaning? What made you choose a name like that? Also, can you explain your tokenomic distribution? How many tokens will be printed? How many tokens will the team lock?

KADES PONJA 🎰, [19.05.21 22:00]
The role of the community is vital for TRIALL

Do you have plan to “educate non crypto people on how to use $TRIALL in sustainable way” in able to be part of your Community?

Talking about non crypto people , like “real-world companies”

Alikaa Azzahra, [19.05.21 22:00]
how many slots are available on the $TRL token presale this time then is there a minimum transaction to participate in the #Triall presale and how do I make a payment during the pre-sale and where can I buy $TRL tokens?

Mic’ Kim, [19.05.21 22:00]
With the COVID-19 pandemic, it is very necessary to implement mechanisms that ensure the acceleration and optimization of clinical trials and investigations, what contributions with blockchain solutions is Triall making to investigations related to the pandemic?
And BTW, do you have plans for HACKATHON so as to check the security of your ecosytem periodically and also invite developers to build?Is #TRIALL a Global project ?

Sub Zero, [19.05.21 22:00]
How will $TRIALL’s efforts stay in the market for such a long time? What makes your platform strong and recommendable to many people? How easy is $TRIALL?

Lovely_DC 💋, [19.05.21 22:00]
Hello @rxvdwaal
Q1. Clinical trials can facilitate safe and efficient data exchange in the clinical field between researchers and their many isolated software systems. With this in mind, why does Triall need Tokens? its utility in your ecosystem? And what are the main use cases?

Q2. When viewing your most recent street Road Map. What’s your next most important clinical priority? Does your team have enough fundamentals like “Funds, Community, etc.” to achieve this? And Do you have a Bug Bounty to check for vulnerabilities in your project?

Muhammad Naufal, [19.05.21 22:00]
Can you give an overview of $TRL Token tokenomics?Will the design of the token rise and fall with the success of the platform,does it include any scarce paths,such as equity, storage or burning?

Ayam Racing, [19.05.21 22:00]
Can you please highlight more on the decentralization aspect using your technology. Also in the future, is it possible to quantify the level of decentralization and economic incentivization?

Alikaa Azzahra, [19.05.21 22:00]
can you provide some deadly features in #Triall from other competitors and the address of the smart contract is security, has it been audited then how is the result, then is there a burning $TRL token from the Ecosystem utility for the community ?

Sub Zero, [19.05.21 22:00]
Can you list some of the features with which you are most confident about your platform? How can you advertise your project worldwide and make it popular?

Ayam Racing, [19.05.21 22:00]
I see that in the last few weeks, it seems clear that the next increase in growth for our industry may be due to the DEFI incentives. That is. yield farming, liquidity mining, rebates, and other methods that value providers have to raise funds by participating. How do you plan to ensure that your platform and in particular the Triall token are meaningfully included in this DEFI token basket and provide the right incentives to attract new users in the same way as any other token?

🌼 Seoyun 서윤 🌼, [19.05.21 22:00]
You mention your team’s published articles on medical research innovation and experiences. Will this feature be enough for you to adapt to the crypto space and be successful? Do you have team members or consultants on crypto-related issues?

Geby, [19.05.21 22:00]
How does TRIALL plan to spread awareness about your project in different countries or regions where English is not well spoken? ‌‌

Ayam Racing, [19.05.21 22:00]
Is transparency a major topic in blockchain? Tell us clearly about the Triall team members. And How many team members do you have and how many developers are working for this Triall?

KADES PONJA 🎰, [19.05.21 22:00]
What was that vision when it first emerged as an idea? Are there any special prototypes or upcoming TriaLL updates that you want to show/share with us?

Geby, [19.05.21 22:00]
Could you tell us a little more about your $TRL tokens? Could you give us details of its distribution, its usefulness and when will you carry out your IDO and on what platform?

Tyo Marthata, [19.05.21 22:00]
In order for your community to be more involved in the development of the #Triall ecosystem, 10% of the total TRL token supply has been allocated to the Triall community fund. So can you provide detailed information about a #Triall community fund and its operations?

Chintya lensley, [19.05.21 22:00]
What difficulties have been encountered during the development of #TRIALL?
What is business model of #TRIALL? How it works? and
Who are your potential customers and which markets are you targeting on?

Aurellia, [19.05.21 22:00]
Exactly which strategy does $TRL use to prevent your token from suffering inflation? How do you prevent the loss of value of your currency?

EsrarengizBTC ☕️, [19.05.21 22:00]
To encourage your community to be more involved in the development of the Triall ecosystem, 10% of the TRL token supply has been allocated to the Triall Community Fund. So, what function does the Triall Community Fund have and what benefit will it provide in your development process?

Messi MA, [19.05.21 22:00]
Do you have any big companies and partner associated with TRIALL and working now?

What is Triall next upcoming plan and marketing activities to grow your project?

Geby, [19.05.21 22:00]
Is the $TRL token going to use the binance smartchain or ethereum network, then what about the security that the UniBright team has with one of the upcoming hackers and will $TRL list on DEX and CEX?

Aurellia, [19.05.21 22:00]
Q. Community support is one of the greatest aspects of the success of your project. Most projects have programs that each user interacts with. Does $TRIALL have a specific plan to attract and expand your community and improve user experience?

Abang Indomaret, [19.05.21 22:00]
can you share a demo or a leak about the main features?? And what is your role on the team??….

Jessica, [19.05.21 22:00]
Is #Triall a global project or a local project? And can users use the #Triall project anywhere and without restrictions?

Veloraa $ C R Y P T O, [19.05.21 22:00]
I see that your mission is to accelerate the introduction of vaccines and therapies for society… In which countries would this project work? Do you plan to also take it to 3rd world countries where it is quite necessary..??

Abang Indomaret, [19.05.21 22:00]
is this the first project you joined??
Can you tell us more about your blockchain experience?what is the background of your team members?What is your status regarding smart contract audits and security mechanisms to protect and reassure current ecosystem participants??….

EsrarengizBTC ☕️, [19.05.21 22:00]
Since I work in the medical industry, I know that a variety of Clinical Trial software is used to assist in research and data collection outside of you. If you see these softwares as a competitor, how is it possible for you to be preferred over them? Why should those who use that software change their habits and use your product?

Abang Indomaret, [19.05.21 22:00]
Can the request explain the various levels on the platform??…

Bill Grimes, [19.05.21 22:00]
/off@amaguardbot

AMA Guard, [19.05.21 22:00]
Group Gem Collectors 💎 session is now Inactive

Bill Grimes, [19.05.21 22:00]
Now that’s a crowd!

Bill Grimes, [19.05.21 22:01]
@rxvdwaal The floor is all yours

Raymond van der Waal, [19.05.21 22:03]
Thanks guys

Raymond van der Waal, [19.05.21 22:03]
See a lot of great questions

Raymond van der Waal, [19.05.21 22:07]
[In reply to EsrarengizBTC ☕️]
Excellent question @esrarengizbtc

There are indeed a variety of clinical trial software solution providers. In fact, this is one of the key problems we are targeting: there’s a lot of software systems that do not interact well.

Our core competitors offer all-encompassing software suites that offer many function-specific tools under one banner, but these are typically only affordable to the largest (say top 20) of pharma companies, quite often run on legacy software, and offer limited options for external integrations. As a result, the majority of the clinical trial industry is still hampered by suboptimal software infrastructures.

Our blockchain infrastructure tackles these issues. Existing clinical trial software providers can connect to us, and thereby interact with other solutions (‘turning competitors into collaborators’). Also, we offer proof of data integrity and authenticity so that the reliability of clinical trials is optimized.

In other words, we’re positioned as a gateway for safe and efficient digital cincial trial activities, offering exisitng systems and clinical trial professionals an easy entry into blockchain and its unique benefits.

Ultimately, this builds towards a true digital ecosystem of clinical trail software systems and clinical trial professionals

Raymond van der Waal, [19.05.21 22:11]
[In reply to kenny kimora]
So let me touch upon the impact of blockchain and crypto:

In clinical trials, it is all about the establishment of conclusive evidence about the safety and efficacy of new vaccines and drugs. Blockchain and related technologies represent incredible tools for ensuring that this evidence is reliable, traceable, and verifiable. These technologies hence provide a solution to the growing number of data integrity issues we witness in our industry.

Moreover, blockchain-enabled technologies such as decentralized identifiers (DIDs) and verifiable credentials (VCs) offer amazing opportunities for improving the way we handle sensitive medical data, in clinical trials but also more generally. Our vision is that DIDs and VCs will shape a decentralized identity and access management layer that revolutionizes data discovery and exchange, optimizing privacy, security, and operational efficiency.

Finally, tokens enable us to lay the groundwork for a self-sustaining digital ecosystem, in which a multi-stakeholder community of clinical researchers, software developers, and (token) investors is incentivized to create and capture utility and value

These are all unique opportunities presented through blockchain and crypto

Raymond van der Waal, [19.05.21 22:14]
[In reply to Jessica]
Relevant question! The token economics of $TRL are designed to drive demand and limit supply.

Key factors that drive TRL demand include:
(1) the release of more software solutions for clients;
(2) sales channels that target new regions across the globe;
(3) ecosystem network effects, by onboarding previously isolated software systems and their end-users into our ecosystem.

Key factors that limit TRL supply include:
(1) a two-token system, in which TRL is converted into T-CRED for each contract and clients pay 6 months upfront for their software subscription;
(2) lock-up incentives such as Triall memberships and rewards;
(3) a token burn policy, in which 2,5% of tokens are permanently burned when converting T-CRED back to TRL;
(4) vesting schedules for all TRL token pools

Raymond van der Waal, [19.05.21 22:16]
[In reply to Veloraa $ C R Y P T O]
That’s a great question! The need for new vaccines and therapeutics is felt globally. We have the ambition to become a truly global initiative.

We will initially focus on business development within the EU & US markets, to gain traction and market dominance.

We have a strong footprint in the EU and US markets, thanks to having managed a lot of clinical trials in the past across Europe and the US. This should provide us with the power to successfully scale our operations to the rest of the world

So in due time, we will expand to the APAC and African regions by setting up satellite offices in these areas.

Our cloud-based technology can easily be rolled out to other areas and, as discussed, we have an existing network of ambassadors and advisors across the globe that can serve as a steppingstone for expanding our sales channels to these geographies

Bill Grimes, [19.05.21 22:19]
Thanks for answering these questions so diligently. Very elaborate and professional answers! Please let us know if you found a winning question?👏

Raymond van der Waal, [19.05.21 22:19]
[In reply to 🌼 Seoyun 서윤 🌼]
Triall houses experts from several medical research disciplines. These include globally recognized thought leaders that have published extensively on topics such as immunology, infectious diseases, vaccinology, microbiology, eHealth technologies, drug and vaccine development.

The team effectively bridges and integrates the medical and crypto domains, as demonstrated by a recent publication in the renowned journal Science Magazine (https://science.sciencemag.org/content/368/6492/719). This Triall-affiliated research article integrates advanced insights from infectious diseases, vaccine development, and blockchain technology into a novel blockchain-enabled system for international cooperation and data-sharing to combat epidemic emergencies.

It truly demonstrates the trans-disciplinary nature of Triall 🙂

Raymond van der Waal, [19.05.21 22:21]
[In reply to Veloraa $ C R Y P T O]
I would say this is my personal favorite :)

Raymond van der Waal, [19.05.21 22:22]
I welcome everyone to join our community t.me/triallcommunity

Raymond van der Waal, [19.05.21 22:22]
Our team members are always there for your to answer any questions or link you to the right resources

Bill Grimes, [19.05.21 22:22]
[In reply to Raymond van der Waal]
Congrats to the winner😄👏

Bill Grimes, [19.05.21 22:23]
And thanks a lot for answering our questions so clearly Raymond. We’ve learned a lot about Triall and are excited for the upcoming months🚀

Chad Roulette, [19.05.21 22:23]
Thanks for the AMA @rxvdwaal Fantastic job and a great project

Bill Grimes, [19.05.21 22:23]
Lots of luck and we’ll see eachother soon🥂

Raymond van der Waal, [19.05.21 22:23]
And for those that haven’t registered for our pre-sale -> go to triall.io and sign up 😉

Raymond van der Waal, [19.05.21 22:24]
Thanks for hosting this guys

Raymond van der Waal, [19.05.21 22:24]
Had a blast answering all of your questions

Raymond van der Waal, [19.05.21 22:24]
I’ll finish with our promo video: https://www.youtube.com/watch?v=WIIyhFl5eeA&t=1s

Bill Grimes, [19.05.21 22:24]
[In reply to Raymond van der Waal]
Very important too ;)

Bill Grimes, [19.05.21 22:25]
Thanks Raymond, also for sharing the vid. Watched it priorly, truly some great info in there!

Raymond van der Waal, [19.05.21 22:26]
Thanks, good night/day/morning everyone

--

--